Revenue | ₹610.83Cr |
Net Profits | ₹121.54Cr |
Net Profit Margins | 19.90% |
Alivus Life Sciences Ltd’s revenue jumped 2.81% since last year same period to ₹610.83Cr in the Q1 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated -7.4% fall in its revenue since last 3-months.
Alivus Life Sciences Ltd’s net profit jumped 9.02% since last year same period to ₹121.54Cr in the Q1 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated -14.33% fall in its net profits since last 3-months.
Alivus Life Sciences Ltd’s net profit margin jumped 6.04% since last year same period to 19.90% in the Q1 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated -7.49% fall in its net profit margins since last 3-months.
The revenue for Alivus Life Sciences Ltd in the Q1 results 2025 was ₹610.83Cr.
The net profit for Alivus Life Sciences Ltd in the Q1 results 2025 was ₹121.54Cr.
The net profit margin for Alivus Life Sciences Ltd in the Q1 results 2025 was 19.90%.
The revenue for Alivus Life Sciences Ltd in the Q1 results 2024 was ₹594.11Cr.
The net profit for Alivus Life Sciences Ltd in the Q1 results 2024 was ₹111.48Cr.
The net profit margin for Alivus Life Sciences Ltd in the Q1 results 2024 was 18.76%.